The global Antacids market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period. Antacids are the over the counter medications used in neutralizing the stomach acid. They mainly work by reducing or preventing the secretion of stomach acids. They are mostly used in treating acid reflux, heartburn, indigestion. Growing prevalence of gastroesophageal reflux diseases and peptic ulcers is one of the primary drivers of the market, creating lucrative opportunities for the pharmaceutical companies to manufacture different drugs to meet the demand.
Global Antacids market growth is driven by increasing prevalence of gastroesophageal reflux diseases, rising prevalence of heartburn, and increasing awareness about GERD and increasing side-effects related to non-steroidal anti-inflammatory drugs.
Increasing prevalence of GERD is one of the dominating factors propelling the global antacids market. For instance, according to a review article published in the International Foundation for Gastrointestinal Disorders in 2014, the prevalence estimates of GERD since 1995, in North America were around 18% to 28%, Europe had 9% to 26%, East Asia had 3% to 8%, Australia had about 12% and 9% to 33% in the Middle East, and 23% in South America. It is also suggested that there was an increase in GERD prevalence since 1995, mainly in North America and East Asia.
Rising prevalence of heartburn is expected to boost the market over the period of forecast. According to the American college of gastroenterology, more than 60 million Americans will experience heartburn at least once a month and more than 15 million Americans experience heartburn symptoms every day.
Increasing awareness about GERD is expected to boost the market. For instance, the International Foundation for Gastrointestinal Disorders has provided the information and support regarding GERDin the 19th Annual GERD Awareness Week, which was in November 2018. Also, it helps in educating individuals related to GERD and supports research regarding treatments and cures for GI disorders.
However, alternative treatment for antacids and increased side-effects related to antacids are hampering the market. For instance, alternative treatments which are likely to restrict the market for antacids include acupuncture, melatonin, hypnotherapy, herbal remedies, baking soda and lifestyle changes. Also, side effects related to antacids include dose-dependent rebound hyperacidity, milk-alkali syndrome, aluminium intoxication, osteomalacia, and hypophosphatemia are restraining the market growth.
North America is dominating the global Antacids market in 2018 and estimated to hold the largest market size over the forecast period (2019-2026). This is owing to the rising prevalence of GERD, increasing the incidence of heartburn, increased awareness of GERD among the consumers.
• North America
• Asia-Pacific (APAC)
• Europe
• South America
• Middle East and Africa (MEA)
Competitive Landscape:
Some of the key players in the Global Antacids market are
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
